Robben J - Search Results

1

Protein profiling of 3T3-L1 adipocyte differentiation and (tumor necrosis factor alpha-mediated) starvation.

Renes J, Bouwman F, Noben JP, Evelo C, Robben J, Mariman E. Renes J, et al. Among authors: robben j. Cell Mol Life Sci. 2005 Feb;62(4):492-503. doi: 10.1007/s00018-004-4498-9. Cell Mol Life Sci. 2005. PMID: 15719175

2

Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines.

Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, Robben J, Renes J. Wang P, et al. Among authors: robben j. Cell Mol Life Sci. 2004 Sep;61(18):2405-17. doi: 10.1007/s00018-004-4256-z. Cell Mol Life Sci. 2004. PMID: 15378209 Free PMC article.

3

SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.

van Diepen JA, Robben JH, Hooiveld GJ, Carmone C, Alsady M, Boutens L, Bekkenkamp-Grovenstein M, Hijmans A, Engelke UFH, Wevers RA, Netea MG, Tack CJ, Stienstra R, Deen PMT. van Diepen JA, et al. Among authors: robben jh. Diabetologia. 2017 Jul;60(7):1304-1313. doi: 10.1007/s00125-017-4261-z. Epub 2017 Apr 5. Diabetologia. 2017. PMID: 28382382 Free PMC article.

4

Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells.

Robben JH, Knoers NV, Deen PM. Robben JH, et al. Mol Biol Cell. 2004 Dec;15(12):5693-9. doi: 10.1091/mbc.e04-04-0337. Epub 2004 Oct 6. Mol Biol Cell. 2004. PMID: 15469988 Free PMC article.

5

Succinate receptors in the kidney.

Deen PM, Robben JH. Deen PM, et al. J Am Soc Nephrol. 2011 Aug;22(8):1416-22. doi: 10.1681/ASN.2010050481. J Am Soc Nephrol. 2011. PMID: 21803970 Review.

6

Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.

Robben JH, Knoers NV, Deen PM. Robben JH, et al. Am J Physiol Renal Physiol. 2006 Aug;291(2):F257-70. doi: 10.1152/ajprenal.00491.2005. Am J Physiol Renal Physiol. 2006. PMID: 16825342 Free article. Review.

7

Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.

Boone M, Kortenoeven M, Robben JH, Deen PM. Boone M, et al. Nephrol Dial Transplant. 2010 Jan;25(1):48-54. doi: 10.1093/ndt/gfp409. Epub 2009 Aug 8. Nephrol Dial Transplant. 2010. PMID: 19666909

8

Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.

Robben JH, Knoers NV, Deen PM. Robben JH, et al. Am J Physiol Renal Physiol. 2005 Aug;289(2):F265-72. doi: 10.1152/ajprenal.00404.2004. Am J Physiol Renal Physiol. 2005. PMID: 16006591 Free article.

9

Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.

Los EL, Deen PM, Robben JH. Los EL, et al. Among authors: robben jh. J Neuroendocrinol. 2010 May;22(5):393-9. doi: 10.1111/j.1365-2826.2010.01983.x. Epub 2010 Feb 12. J Neuroendocrinol. 2010. PMID: 20163515 Review.

10

Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application.

Robben JH, Deen PM. Robben JH, et al. BioDrugs. 2007;21(3):157-66. doi: 10.2165/00063030-200721030-00003. BioDrugs. 2007. PMID: 17516711 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page